Who backs Angitia Biopharmaceuticals?
24 investors| Investor | Type |
|---|---|
| Oriza Holdings | Asset manager |
| RA Capital Management | Asset manager |
| GL Ventures | Venture capital |
| Legend Capital | Venture capital |
| OrbiMed | Growth equity |
| 5Y Capital | Other |
| Yonghua Capital | Other |
| CMB International Capital | Asset manager |
| Hillhouse Investment Group | Other |
| Venrock | Venture capital |
| + 14 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Angitia Biopharmaceuticals
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 24 firms already write checks for companies like Angitia Biopharmaceuticals in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.